Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1826-6983
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients ; volume:126 ; number:9 ; day:3 ; month:6 ; year:2021 ; pages:1249-1254 ; date:9.2021
La Radiologia medica ; 126, Heft 9 (3.6.2021), 1249-1254, 9.2021
- Creator
-
Detti, Beatrice
Scoccianti, Silvia
Teriaca, Maria Ausilia
Maragna, Virginia
Lorenzetti, Victoria
Lucidi, Sara
Bellini, Chiara
Greto, Daniela
Desideri, Isacco
Livi, Lorenzo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11547-021-01381-5
- URN
-
urn:nbn:de:101:1-2021110521415228460072
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Detti, Beatrice
- Scoccianti, Silvia
- Teriaca, Maria Ausilia
- Maragna, Virginia
- Lorenzetti, Victoria
- Lucidi, Sara
- Bellini, Chiara
- Greto, Daniela
- Desideri, Isacco
- Livi, Lorenzo
- SpringerLink (Online service)
Other Objects (12)
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma